Connect with us

Health

Merck, IFFS Tackle Infertility In Africa

Published

on

infertility-in-africa

By Modupe Gbadeyanka

Leading science and technology company, Merck, through its ‘Merck More than a Mother’, has conducted a high level panel to addressed infertility challenges in Africa, with a view to finding solutions to them.

The panel was set in partnership with the International Federation of Fertility Societies (IFFS) at the opening ceremony of the World Congress of (IFFS) held in New Delhi, India.

The high level panel of ministers, parliamentarians and global fertility experts from IFFS and Africa Fertility Society highlighted lack of access to regulated fertility care and awareness about infertility management and widespread stigma of infertile women as some of the key challenges in Africa.

The panel called for increased efforts to improve access to regulated fertility care through the development of artificial reproductive therapy (ART) laws and regulations and to empower infertile women through access to education and information. They also supported the training of African embryologists and discussed different interventions to remove the infertility stigma and create a culture shift and change of mind set.

The high level panel including Sarah Opendi, Minister of Health, Uganda; Betty Amongi, Uganda’s Minister of Lands, Housing and Urban Development and Chair of Uganda Women Parliamentarian Association; Julia Duncan-Cassell, Minister of Gender, Liberia; Joyce Lay, Member of Parliament, Kenya; Dr Patrick Amoth, Senior Deputy Director of Medical Services, Ministry of Health, Kenya; Prof. Joe Leigh Simpson, Former President of International Federation of Fertility Societies (IFFS); Prof. Richard Kennedy, President of IFFS; Prof. Oladapo Ashiru, President of Africa Fertility Society; Dr. James Olobo-Lalobo, Vice-President of Africa Fertility Society, Uganda and Dr. Rasha Kelej, Chief Social Officer, Merck Healthcare supported the implementation of ‘Merck More than a Mother’s’ strategic objectives and interventions across Africa.

“The aim of ‘Merck More than a Mother’ is to empower infertile women in Africa through improving access to education, information and health and change of mind-set and in case they cannot be treated the campaign is empowering them economically and socially through ‘Empowering Berna’ Project so that they can be independent and re-build their own lives,” said Dr. Rasha Kelej, Chief Social Officer, Merck Healthcare.

“In Uganda, between 15-20% of couples fail to conceive. The number of fertility clinics in the country to address this problem are few and expensive. Together with ‘Merck More than a Mother’ in Uganda we are creating awareness that infertility can be prevented and that to improve access, fertility care can be integrated into the already existing public reproductive healthcare services which will be cost effective as the infrastructure is already there. In addition we are building a hospital for Women Health where we will dedicate an IVF center to provide couples with affordable and effective treatment with the support of Merck to train the future staff,” said Sarah Opendi, the Minister of Health, Uganda.

“In our culture, a woman is always blamed for infertility. She carry’s the shame, embarrassment and tears in private. We need to create awareness by providing information and education on infertility so that both men and women can talk about it. ‘Merck More than a Mother’ campaign has opened discussions on infertility and is talking about solutions and interventions available,” said Joyce Lay, Member of Parliament, Kenya.

At the meeting Merck showed a few videos of African infertile women who shared their stories of suffering due to failing to have children and their transformation after meeting Merck more than a Mother team who helped empower them socially and economically.

Speaking on the need to create a culture shift, Julia Duncan Cassell, Minister of Gender, Liberia said: “We should look at a woman as more than a mother. It is not always the fault of the woman when there is no child, but in our culture it is. We need to speak out as both men and women can be affected by infertility. Violence and stigma against infertile women should not be tolerated. We need to change our culture, tradition, attitude and mind-set. These can be modified and changed. We hope the ‘Merck More than a Mother’ initiative can be extended to other African countries so that awareness can increase and know that infertility can be caused by many factors and that with the right information it can be prevented.”

“In the African culture, marriage gives a woman the right to property and land. When they don’t bear children they are disinherited and when they go back home there is also nothing for them. Therefore, empowering infertile women economically and socially as ‘Merck More than a Mother’ is doing is important because most of them have nowhere to go. This enables them to sustain themselves and with the information they are given they become change agents in their communities,” said Betty Amongi, Minister of Lands, Housing and Urban Development, Uganda.

Prof. Joe Leigh Simpson, President of IFFS supported the need and importance of building fertility care capacity in Africa. “We in high resource countries have an obligation to provide education, service and translate in the shortest period of time the advances that are being made in our labs to middle and low resource countries”.

“IFFS has an important role to support ‘Merck More than a Mother’. We agree that education is essential and that we will support the education and training initiatives necessary in Africa to develop capacity for infertility treatment,” said Prof. Richard Kennedy, President elect of IFFS.

“In Nigeria people who come into our clinics are afraid because they don’t want people to know they are taking fertility treatment. In most of these cases only women seek treatment for infertility and not the men. People prefer to seek help elsewhere and by the time they come for medical help it is too late. We are happy that ‘Merck More than a Mother’ campaign is being launched in Nigeria and in Africa to create a culture shift that will enable people to seek proper treatment for infertility and that there is respect for womanhood than motherhood,” emphasized Prof. Oladapo Ashiru, President Africa Fertility Society.

Dr. Patrick Amoth, Senior Deputy Director of Medical Services, Ministry of Health Kenya pledged support for the work that ‘Merck More than a Mother’ is doing in Kenya. “The Ministry will play a key role in developing policy and guidelines to implement the ART law to ensure standards and regulations are maintained to protect couples seeking fertility treatment from exploitation,” he emphasized.

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

NAFDAC Announces Recall of WAP Sensual Enhancement Capsules

Published

on

WAP Sensual Enhancement Capsules

By Aduragbemi Omiyale

The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a sexual enhancement product known as WAP Sensual Enhancement Capsules.

In a statement on Monday, the Nigerian agency disclosed that the recall is due to “undeclared pharmaceutical ingredients” in the product, whose country of origin is unknown, but is marketed and distributed online in the US through eBay.

It was emphasised that the recall is being “voluntarily” made by the manufacturer, Best Supplements Best Prices Company.

The detection of the undeclared pharmaceutical ingredients was made by the US Food and Drug Administration (FDA).

Laboratory analysis by the US FDA revealed that the product contained undeclared sildenafil, tadalafil, and flibanserin, which were not mentioned on the product label. Such substances may include phosphodiesterase type-5 (PDE-5) inhibitors or related compounds commonly used for the treatment of erectile dysfunction, the statement by NAFDAC stated.

Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction.

It was noted that these undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, dangerously low blood pressure, and fainting, especially when combined with alcohol.

Consumers have been encouraged to report compromised products (medicines or medical devices) to the nearest NAFDAC office, call 0800-162-3322, or send an email to sf******@********ov.ng.

Continue Reading

Health

Tinubu Chooses Obi Adigwe Coordinator of Health Tech Data Analytics Office

Published

on

obi adigwe

By Modupe Gbadeyanka

Dr Obi Adigwe has been appointed as the pioneer National Coordinator of the National Health Technology and Data Analytics Office (NHTDAO).

The body was created by the Ministry of Health under the approval of President Bola Tinubu.

NHTDAO will be domiciled in the Office of the Coordinating Minister of Health and Social Welfare, a statement on Friday by the Special Adviser to the President on Information and Strategy, Mr Bayo Onanuga, stated.

The agency will serve as a meta-level national platform for coordinating the country’s digital-health agenda. It will reinforce, not replace, the existing statutory functions of relevant departments and agencies, it was emphasised.

The organisation will also harmonise and empower the public and private institutions across the health system, set the standards that connect them, and operationalise the National Digital Health Architecture, approved by the National Council on Health in November 2025.

It was stated that President Tinubu expects NHTDAO to accelerate Nigeria’s transition to a secure, interoperable and data-driven health system that improves outcomes for all citizens.

Mr Adigwe, as Director General of the National Institute for Pharmaceutical Research and Development, has leveraged science to catalyse interventions in artificial intelligence, translational research, and technology transfer.

He coordinated major projects, including the ¥300m Nanotechnology grant and the AFREXIMBank grant for Africa’s first API Training Facility. He led the roadmap development that underpinned an €18 million EU grant, the largest in Africa for the thematic area. During the last pandemic, Adigwe globally showcased African science by undertaking the world’s first analysis to debunk claims about the Covid Organics preparation.

The Office’s Steering Committee, which provides strategic direction and oversight, comprises:

  • Professor Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare (Co-chair)
  • Mr Olaniyi Yusuf, Chairman of the Nigerian Economic Summit Group (Co-chair)
  • Dr Iziaq Adekunle Salako, Minister of State for Health and Social Welfare (Alternate Co-chair)
  • Ms Kachollom Daju, Permanent Secretary, Federal Ministry of Health and Social Welfare
  • Mr Idris Alubankudi Saliu, Special Adviser to the President on Technology and Digital Economy
  • Dr Muntaqa Umar-Sadiq, National Coordinator, SWAp Coordination Office
  • Dr Abdu Mukhtar, National Coordinator, Presidential Initiative to Unlock Healthcare Value Chain
  • Dr Muyi Aina, Executive Director, National Primary Health Care Development Agency
  • Dr Kelechi Ohiri, Director General, National Health Insurance Authority
  • Director, Health Planning, Research and Statistics, Ministry of Health and Social Welfare
  • National Information Technology Development Agency Representative
  • Six representatives of the State Commissioners of Health, one from each of the six geopolitical zones
  • Pharm Hamza Buhari, Stakeholder representing Industry and Community.
Continue Reading

Health

Lagos Commences Screening of Newborns for Sickle Cell Disease

Published

on

sickle cell disease screening Lagos

By Modupe Gbadeyanka

The Lagos State government has kicked off an initiative to ensure that every newborn is screened for Sickle Cell Disease within 48 to 72 hours after birth using a simple heel-prick test.

It was gathered that babies identified as being at risk will immediately be placed on preventive care while awaiting confirmatory testing.

The Head of the Haematology Department at the Alimosho General Hospital, Dr Olubukola Orolu, revealed that an estimated 150,000 babies are born annually with Sickle Cell Disease in Nigeria, giving the country one of the highest SCD burdens globally.

She, however, applauded the Lagos State Government and the Clinton Health Access Initiative (CHAI) for introducing the state-wide newborn screening programme, describing it as a major step towards reducing childhood deaths associated with the disease.

The commencement of this scheme coincides with the 2026 World Sickle Cell Day, themed Young Voices Rising for Sickle Cell Disease – Closing the Survival Gap: Equity in Sickle Cell Disease.

It highlights the importance of listening to the experiences and aspirations of young people living with Sickle Cell Disease.

Mrs Orolu noted that SCD warriors are increasingly breaking barriers as advocates, leaders, students and change-makers, adding that their voices have continued to reshape the narrative through advocacy for equitable, patient-centred healthcare, self-care and experience sharing.

She, therefore, called for equal access to quality healthcare, survival opportunities and dignity for everyone living with Sickle Cell Disease.

Also commenting, the chief executive of Alimosho General Hospital, Dr Akinyele Akinlade, described Sickle Cell Disease as an inherited blood disorder that is not contagious, noting that individuals living with the condition are more susceptible to infections.

He advised SCD warriors to stay well hydrated, avoid stress, and protect themselves from extreme cold or heat, as these are common triggers of sickle cell crises, adding that these preventive measures can significantly reduce the frequency and severity of crises.

One of the participants, Ms Borokini Zainab, an SCD warrior and student nurse, expressed appreciation to the organisers for the enlightenment programme.

Sharing her personal journey, she spoke about the challenges of balancing recurrent pain crises with her academic pursuits and personal life. Despite moments of frustration, she encouraged fellow warriors not to lose hope.

“Don’t let sickle cell put you down. Be encouraged from within. Don’t let your dreams be shattered because of this,” she said, adding that her personal experience with Sickle Cell Disease inspired her to pursue a career in nursing so she could support others living with the condition.

Continue Reading

Trending